<DOC>
	<DOCNO>NCT01739777</DOCNO>
	<brief_summary>The purpose study determine safety clinical effectiveness umbilical cord mesenchymal cell transplant intravenous infusion patient heart failure .</brief_summary>
	<brief_title>Randomized Clinical Trial Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells Cardiopathy</brief_title>
	<detailed_description>Phase I-II Clinical Trial - Safety efficacy umbilical cord derive mesenchymal stem cell ( ucMSC ) patient heart failure Randomized , double blind , control prospective study patient compensate heart failure dilate phase . Thirty patient select , undergo strict 3-month followup ventricular function sequentially randomize two group : first group 15 patient receive sole injection ucMSC remain 15 patient comprise control group . Every patient maintain standard treatment heart failure , maximum tolerated dosage without side effect . The day infusion consider day zero . From moment , followup divide 0-3 , 3-6 , 6-12 month . Clinical result analyze completion 12 month followup .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Symptomatic heart failure patient dilate stages Etiologies : dilate cardiomyopathy , chronic hypertensive cardiopathy dilate stage , chronic coronary cardiopathy dilate stage Ejection fraction â‰¤ 40 % . Patients stable optimal medical treatment period least 3 month prior randomization Severe persistent heart failure Recurrent myocardial ischemia Uncontrolled ventricular tachycardia Malignant disease ( life expectancy le one year ) Manifest ventricular asynchrony Hematologic disease Recent cerebrovascular disease Recent acute coronary syndrome Serum creatinine &gt; 2.26 mg/dL ( 200 umol/L ) Atrial fibrillation without heart rate control last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Coronary Heart Disease</keyword>
	<keyword>Adult Stem Cells</keyword>
	<keyword>Umbilical Progenitor Cells</keyword>
	<keyword>Umbilical Cord Stem Cells Allogenic</keyword>
	<keyword>Left Ventricular Function</keyword>
	<keyword>Intravenous Injection</keyword>
</DOC>